Biotech entity
All 1 tracked stories fall under one category: pharma. Morgan Stanley is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. We currently track 1 Biotech story that mention Suzuken Co., Ltd., all published on August 4, 2026.
Last mentioned: Aug 4, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: pharma. Morgan Stanley is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. We currently track 1 Biotech story that mention Suzuken Co., Ltd., all published on August 4, 2026. Each carries 1 original source on average.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 12 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Suzuken Co., Ltd.. Shared-story counts are live from our verified record — not editorial picks.
A 114% short interest surge in Towa Pharmaceutical contrasts with a Morgan Stanley upgrade, spotlighting the tension between bearish OTC bets and fundamental analysis of Japan’s drug R&D landscape.
Source: themarketsdaily.com
Suzuken Co., Ltd. is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
